Liz Highleyman
Articles
-
6 days ago |
cancerhealth.com | Liz Highleyman
Use of popular weight-loss medications, such as semaglutide and tirzepatide, was associated with a moderately lower risk for obesity-related cancers, especially colon and rectal cancer, and reduced overall mortality compared with another widely used class of diabetes drugs, according to a study presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place this week Chicago.
-
1 week ago |
poz.com | Liz Highleyman
HIV vaccine approaches that aim to train the immune system to produce specialized antibodies against the virus have taken the next steps forward, two research teams reported in Science to coincide withHIV Vaccine Awareness Dayon May 18. Both studies showed that different engineered immunogens could trigger production of precursor immune cells with the potential to produce broadly neutralizing antibodies (bnAbs) that work against diverse strains of HIV.
-
2 weeks ago |
cancerhealth.com | Liz Highleyman
On May 15, the Food and Drug Administration (FDA) approved Zynyz (retifanlimab) immunotherapy for people with advanced anal cancer based on promising results from a late-stage clinical trial. This makes it the first-ever approved first-line therapy for this population, including people living with HIV.
-
2 weeks ago |
poz.com | Liz Highleyman
Transgender people who receive gender-affirming hormone therapy appear to have better HIV outcomes, according to a new study published in The Lancet HIV. As the proportion of trans and gender-diverse people receiving hormone therapy rose at two primary care clinics, HIV prevalence and the likelihood of not having viral suppression declined. “Gender-affirming care is important for optimizing HIV outcomes among trans people,” the study authors concluded.
-
2 weeks ago |
realhealthmag.com | Liz Highleyman
Transgender people who receive gender-affirming hormone therapy appear to have better HIV outcomes, according to a new study published in The Lancet HIV. As the proportion of trans and gender-diverse people receiving hormone therapy rose at two primary care clinics, HIV prevalence and the likelihood of not having viral suppression declined. “Gender-affirming care is important for optimizing HIV outcomes among trans people,” the study authors concluded.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- Tweets
- DMs Open
Exactly. Let the science advance & let people decide if they want lab-grown meat. It's quite a hypocritical stance coming from the party that's newly discovered a devotion to animal rights when it comes to medical testing.
Hate this. If it's the best beef in the world, let it compete on the open market. If people want to buy lab-grown meat, that's their problem. Awful to see Republicans adopt the protectionist mindset, with a healthy dose of bureaucratic overreach. Bleh
RT @SolarHam: A cool looking M4.7 solar flare was just observed around AR 4087 peaking at 18:11 UTC (May 14). Image by SDO/AIA 304a. https:…
I’m actually more impressed with Grok & other LLMs than I expected to be (having studied AI in the 1980s). We might need to worry about the malfeasance of the creators more than the programs themselves. https://t.co/yhs0ZICxvA
Verbatim instruction by its “creators at xAI” on “white genocide”, according to Grok. Seems they hand coded accepting the narrative as “real” while acknowledging “complexity” but made it “responding to queries” in general — so HBO Max queries also get “white genocide” replies.🙄 https://t.co/M2Tqr0YFYf